Bipartisan MVP Act Aims to Modernize Medicaid Access to Gene Therapies

The MVP Act introduces outcome-based payment models and installment plans to help Medicaid cover the high costs of life-saving gene therapies. This legislative push seeks to update pricing regulations and ensure patients have sustainable access to cutting-edge medical treatments.